Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 72%
filed 2026-06-04
Item 8.01
The filing discloses that the Android version of SafeDeal Connect, the Company's core mobile application, was removed from the Google Play Store and remains unavailable. This represents a material disruption to the Company's primary product offering and user accessibility, affecting a significant portion of the mobile user base. While the Company is working to restore availability, the inability to provide a definitive restoration timeline due to Google's review process creates material uncertainty about product availability and revenue impact.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-04
Item 5.03
The company executed a 1-for-500 reverse stock split, effective June 5, 2026, reducing outstanding shares from approximately 20.2 billion to approximately 40.4 million. The reverse split was approved by the Board and shareholders and was accompanied by a name change and trading symbol change.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 1.01
Northwest Natural Holding Company entered into a Note Purchase Agreement on June 4, 2026, to issue $120 million in aggregate principal amount of senior notes across three series (Series E, F, and G) with maturities ranging from 2031 to 2036, creating material direct financial obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-04
Item 8.01
NW Natural Water Company, LLC, a subsidiary of Northwest Natural Holding Co, issued $75 million in aggregate principal amount of senior notes ($33M Series A at 5.15% due 2031 and $42M Series B at 5.58% due 2036) on June 4, 2026, with proceeds to be used for general corporate purposes and repayment of existing indebtedness.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 7.01
The Company declared a monthly distribution for its shareholders, specifying per-share amounts across six share classes with varying distribution fees. This routine REIT distribution disclosure is material to investors assessing income yield and cash flow.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 2.03
KKR Private Equity Conglomerate LLC increased its revolving credit facility by $100 million, raising total commitments from $1.0 billion to $1.1 billion with an accordion feature allowing expansion to $1.5 billion. This routine credit facility expansion affects the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-04
Item 2.03
Franklin BSP Real Estate Debt, Inc. entered into a Master Repurchase Agreement with Barclays Bank PLC with no maximum commitment and no initial maturity date, creating a direct financial obligation. This unlimited commitment structure and perpetual nature make it material to investors assessing the Company's capital structure and leverage.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 2.03
Nordson established a $1.2 billion commercial paper program on June 2, 2026, creating a direct financial obligation under Item 2.03. While this is a material financing arrangement that would affect investor assessment of the company's liquidity and capital structure, it does not fit cleanly into the more specific event categories (it is not a covenant breach, dilutive issuance, or M&A activity). The commercial paper program represents a new debt facility rather than a discrete material event like a restatement or executive change, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
This disclosure reports a material regulatory settlement in PSCo's electric rate case with the Colorado Public Utilities Commission, resulting in a $225 million revenue increase (6.3%) and a 9.3% ROE. While regulatory rate proceedings are significant to utility investors, this settlement does not fit neatly into the standard 8-K event taxonomy—it is neither a discrete M&A transaction, covenant breach, impairment, nor executive action. The disclosure is material because it affects PSCo's future revenue and profitability, but the event type is best classified as "other_material" given the regulatory settlement context.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 7.01
The filing discloses a press release providing an update on operating metrics for Q2 2026 under Item 7.01 (Regulation FD Disclosure). While this resembles an earnings release in substance, it is explicitly characterized as an "update on certain operating metrics" rather than a full financial results disclosure, and is filed under Item 7.01 rather than Item 2.02 (Results of Operations). The material nature of operating metrics for a transportation company and the public announcement warrant materiality classification, but the ambiguity between partial operating metrics and full earnings results supports the broader "other_material" category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 1.01
Arch Capital entered into an underwriting agreement to issue $2.0 billion in senior notes, consisting of $600 million due 2036 at 5.250% and $1.4 billion due 2056 at 5.950%. The offering was priced on June 2, 2026, representing a material debt financing event affecting the company's capital structure and financial obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-03
Item 8.01
The filing discloses a press release dated June 3, 2026, under Item 8.01 (Other Events) but provides no substantive detail about the press release's content. Without access to Exhibit 99.1, the specific event cannot be determined. Given Comcast's size and the formal 8-K filing, the event is likely material, but the event type cannot be reliably classified without knowing what the press release announces.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
ADC Therapeutics announced positive topline data from the Phase 3 LOTIS-5 confirmatory trial of ZYNLONTA plus rituximab in relapsed/refractory DLBCL, meeting the primary endpoint of progression-free survival (HR=0.73, p=0.008) with improved overall response and complete response rates versus R-GemOx, supporting a planned supplemental BLA submission.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 5.03
Sphere 3D filed articles of amendment on May 29, 2026, establishing a new Series I Preferred Stock with 8% PIK dividends, conversion rights contingent on CEO Joel Block's tenure, liquidation preferences, and a Nasdaq Exchange Cap limitation. This creates a new class of senior securities with significant economic rights and protective provisions affecting capital structure and dilution risk.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
Everest Group is disclosing a material restructuring of its reportable segments effective January 1, 2026, following the sale of its Commercial Retail Insurance business to AIG. The company is recasting significant sections of its 2025 Form 10-K (Business, MD&A, Financial Statements, and Segment Reporting) to retroactively reflect the new three-segment structure (Reinsurance Treaty, Global Wholesale & Specialty, and Legacy). While this is a segment reorganization rather than a discrete event type in the taxonomy, it represents a material change in how the company manages and reports its business that would affect investor understanding of financial performance and composition.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 7.01
The disclosure describes negotiations to amend the Master Services Agreement with Grand Canyon University, the Company's most significant partner representing a substantial portion of revenue. The proposed amendments would extend the initial term by eight years, restructure fee calculations, eliminate GCU's termination-for-convenience rights, and modify non-renewal fees. The Company acknowledges potential revenue reductions of $4–6 million in Q3–Q4 2026 and operating income impact up to $1 million per quarter, which is material to investor assessment. While this is a potential material contract amendment rather than a completed M&A transaction or other more specific event type, it warrants disclosure as a material event affecting the registrant's most critical business relationship.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 8.01
TransCode disclosed results from its Phase 1a dose escalation clinical trial for TTX-MC138 via press release on June 3, 2026. While this is a clinical trial update rather than a formal earnings release, the disclosure of Phase 1a trial results for a therapeutic candidate is material to investors evaluating the company's pipeline progress and development timeline. The forward-looking statements section explicitly references "the timing, conduct and results of TransCode's Phase 1a and Phase 2a clinical trials" and "the therapeutic potential of TTX-MC138," confirming the materiality of these trial results to the company's prospects.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 8.01
The Company entered into a Consent Agreement with CoBank and other lenders regarding its Credit Agreement, using $68 million of proceeds from the tower sale transaction to repay revolving loan debt. The consent arrangement reflects material debt management and lender coordination in connection with the asset sale.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 1.01
The filing discloses entry into a material definitive agreement (Item 1.01) — specifically a Ninth Amendment to a Loan and Servicing Agreement dated December 2, 2015, extending the maturity date from June 2, 2026, to September 30, 2026. While this is a debt refinancing or extension activity, it does not fit cleanly into the M&A taxonomy (which focuses on acquisitions, dispositions, mergers, or changes of control). The amendment extends an existing credit facility rather than creating a new material acquisition or disposition, making "other_material" the most appropriate classification for this debt restructuring event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 1.04
Hallador Energy's subsidiary Sunrise Coal received an imminent danger order from MSHA on May 28, 2026, under Section 107(a) of the Mine Act at Oaktown Fuels Mine No. 1. While this is a mandatory Item 1.04 disclosure under Dodd-Frank Section 1503, the event itself—a regulatory safety order at an operating mine—is material to investors assessing operational and regulatory risk, even though no injuries occurred and production was not interrupted. The company disputes the order and reserves the right to contest it.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 7.01
The Board of Directors authorized an increase in the company's share repurchase program from $35 million to $50 million, reflecting management confidence and a material capital allocation decision.
View raw filing on EDGAR →
8-K
Other material
confidence 45%
filed 2026-06-03
Item 3.03
Item 3.03 discloses a material modification to the rights of security holders, incorporating Item 1.01 by reference. The specific nature of the modification cannot be fully determined from the available information.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
The disclosure describes the consummation of a $150 million IPO and concurrent $3.45 million private placement by a SPAC (special purpose acquisition company), with proceeds placed in trust. While this is a material capital-raising event affecting the registrant's financial position, it does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, or dilutive issuance in the traditional sense). SPACs are structured differently from operating companies, and the IPO itself is the primary business event rather than a subsequent equity issuance.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
IDEAYA announced a clinical collaboration with Roche to evaluate IDE892 (PRMT5 inhibitor) in combination with RG6505 (pan-RAS inhibitor) in MTAP-deleted pancreatic cancer. This represents a material strategic partnership with a major pharmaceutical company that advances the Company's clinical development pipeline and validates its lead compound in a combination setting. While this does not fit neatly into the more specific event categories (it is not M&A, litigation, impairment, or a traditional earnings/executive event), the collaboration with Roche and the planned Phase 1 combination cohorts constitute material developments affecting the Company's business prospects and investor assessment.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 8.01
REGENXBIO commenced a shareholder-approved Stock Option Exchange Program permitting non-executive employees to exchange underwater stock options with an exercise price of $18.00 or greater for new options granted at fair market value, affecting the company's equity incentive structure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
Dyne Therapeutics announced full enrollment of the registrational expansion cohort (REC) of its Phase 1/2 ACHIEVE trial for z-basivarsen in DM1 patients, with 71 participants enrolled. The company disclosed material clinical development milestones including planned topline data in Q1 2027 and potential BLA submission for Accelerated Approval in Q3 2027, representing significant progress for its lead program.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 7.01
Cardiff Oncology disclosed Phase 2 CRDF-004 clinical trial data and registrational study plans for onvansertib via an investor presentation under Regulation FD. While this represents material clinical development information that would affect investor assessment of the company's pipeline and regulatory pathway, it does not fit neatly into the standard taxonomy categories (not an earnings release, M&A activity, executive change, or other specifically defined event). The disclosure is material because clinical trial results and regulatory strategy are central to a biotech company's valuation and investor decision-making.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
ATI Inc. announced its intention to conduct an underwritten public offering of seven-year senior notes. While this is a material financing event that would affect investor assessment of the company's capital structure and liquidity, it does not fit neatly into the more specific categories (dilutive_issuance applies to equity, not debt; ma_activity covers acquisitions/dispositions). The disclosure is material but represents a debt financing announcement rather than a discrete event type in the taxonomy.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
CECONY entered into an underwriting agreement on June 1, 2026 to issue $1.3 billion in aggregate principal amount of debentures ($450 million 5.15% due 2036 and $850 million 5.875% due 2056). While this is a material debt issuance affecting the registrant's capital structure and financial position, it does not fit the specific taxonomy categories: it is not a dilutive equity issuance (Item 3.02), not a material acquisition or disposition (Item 1.01/2.01), and not a restatement, auditor change, or other enumerated event. The disclosure is material to investors as it represents a significant financing activity, but the most appropriate classification is other_material given the absence of a dedicated debt issuance category.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 5.03
FONAR amended and restated its Certificate of Incorporation effective at the Effective Time of the merger, and modified security holder rights in connection with the transaction.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
PG&E completed a $2.2 billion debt issuance of First Mortgage Bonds across three tranches (2031, 2036, and 2056 maturities) on June 3, 2026. While material financing activity, this does not fit the specific taxonomy categories: it is not M&A, not a dilutive equity issuance, and not a covenant breach or going-concern disclosure. The disclosure is material to investors as it reflects the company's capital structure and financing strategy, but the 8-K Item 8.01 treatment and the nature of the transaction (routine debt financing for a regulated utility) suggest classification as other_material rather than a more specific event type.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
Item 1.01
This disclosure describes entry into a dealer manager agreement for distribution of fund units and shares, with a servicing fee structure of up to 0.85% of NAV per annum. While Item 1.01 typically covers M&A activity, this agreement is a material definitive agreement governing the fund's distribution infrastructure and fee arrangements. The agreement is material to investors as it establishes the economic terms and distribution mechanism for the fund's securities, but does not fit cleanly into the M&A taxonomy (no acquisition, merger, or change of control is occurring).
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
Danaher completed a material private placement of CHF 2.26+ billion in senior unsecured notes across seven series with maturities from 2031 to 2056, with proceeds to be used for general corporate purposes including acquisitions and share repurchases.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
PSEG completed a $500 million public offering of senior notes due 2031 on June 3, 2026. While debt issuances are material financing events affecting the registrant's capital structure and financial position, this disclosure does not fit neatly into the more specific event categories (it is not M&A, a dilutive equity issuance, or a covenant breach). The filing is a routine debt offering disclosure under Item 8.01, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
This 8-K discloses the issuance of $5 billion in debt securities ($2.5B 4.972% Fixed/Floating Rate Notes due 2032 and $2.5B 5.425% Fixed/Floating Rate Notes due 2037) by Goldman Sachs on June 3, 2026 pursuant to its shelf registration. While debt issuances are material financing events affecting the registrant's capital structure and liquidity, they do not fit neatly into the standard taxonomy categories (not M&A, not dilutive equity, not a restatement or going-concern issue). This is a material capital markets transaction disclosed via Item 9.01 (Exhibits).
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 8.01
Vroom disclosed amendments to two material warehouse credit facilities on May 29, 2026. Amendment No. 28 to Warehouse Credit Facility One extends the Commitment Termination Date by one month (June 2 to July 2, 2026), while Amendment No. 10 to Warehouse Credit Facility Two reduces advance rates, lowers the Minimum Tangible Net Worth covenant, and adjusts liquidity calculations. These amendments to material financing arrangements would affect a reasonable investor's assessment of the company's liquidity and financial flexibility, but the disclosures do not clearly indicate a covenant breach, going-concern issue, or other more specific event type—making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
ATI Inc. announced the pricing of an unsecured senior notes offering (5.875% due 2033) on June 3, 2026. This is a material debt issuance that would affect investor assessment of the company's capital structure and financial obligations, but it does not fit neatly into the more specific event categories (it is not a dilutive equity issuance, M&A activity, or a financial restatement). The disclosure is appropriately classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-06-03
Item 7.01
The filing discloses an "operations and financial update" via press release filed with Canadian Securities Regulatory Authorities. While the Item 7.01 disclosure itself is vague and non-specific, the reference to a press release providing "operations and financial update" suggests material business information. Without access to the actual press release (Exhibit 99.1), the precise nature of the update cannot be determined—it could relate to earnings, material events, or other developments. Given the ambiguity and the Regulation FD safe-harbor language, this is classified as other_material rather than a more specific category.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
The filing discloses entry into Amendment No. 1 to an Intellectual Property License Agreement with BP United on June 1, 2026, which materially modifies the original IP Agreement dated May 12, 2026. The amendment restructures consideration (retaining $5M cash, issuing vesting shares), eliminates a planned Supply Agreement, and substitutes manufacturing and consulting services. While Item 1.01 is titled "Entry into a Material Definitive Agreement," the substance is an amendment that restructures an existing deal rather than a standalone M&A transaction, acquisition, or disposition. The materiality to investors is clear (cash retention, equity issuance, operational restructuring), but the event does not fit cleanly into the M&A taxonomy categories.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
The filing discloses two material debt events: (1) Amendment No. 1 extending the maturity of a $1.25M senior note from June 30, 2026 to November 15, 2026 and removing a prior event of default related to preferred share authorization; and (2) issuance of $312.5M in aggregate principal unsecured promissory notes due November 15, 2026 for $250K proceeds. While Item 1.01 (material definitive agreement) and Item 2.03 (direct financial obligation) are disclosed, the substance involves debt restructuring and new financing that does not cleanly fit the taxonomy categories—it is neither a covenant breach (no violation alleged), nor a going-concern disclosure, nor a dilutive issuance (debt, not equity). The extension of maturity and removal of a prior default event suggest financial stress, making this material to investors but best classified as other_material given the hybrid nature of debt amendment and new financing.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 1.01
The Company entered into a Software Development Agreement with Nexe Cloud Limited on May 28, 2026, to design and develop an enterprise business intelligence system spanning six major workstreams (architecture, infrastructure, data warehouse, integration, visualization, and analytics). While Item 1.01 typically covers M&A activity, this is a material service contract for enterprise software development with a first milestone payment of $300,000 and a one-year term. The scope and strategic importance (centralized intelligent ecosystem supporting enterprise-wide planning) suggest materiality, but the event does not fit the M&A taxonomy (no acquisition, merger, or change of control) and is best classified as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 7.01
The company disclosed on June 3, 2026 that it is "exploring strategic alternatives," which signals potential material corporate action such as a sale, merger, restructuring, or other significant strategic change. While the specific nature of the alternatives is not detailed in this Item 7.01 disclosure, the announcement itself is material to investors as it indicates the company is considering fundamental changes to its business or structure. This does not fit neatly into the M&A taxonomy categories (which typically require entry into, completion, or termination of a transaction) but represents a material event that would affect investor assessment of the registrant's future direction.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
The filing discloses the Company's intention to pursue a Commissioner's National Priority Review Voucher contingent on positive interim/final analysis results from its tafenoquine trial in severe babesiosis patients, with potential NDA submission targeted before Q1 2028. This represents a material regulatory development plan for a clinical-stage pharmaceutical company, but does not fit neatly into the standard taxonomy categories (not an earnings release, executive change, M&A, impairment, or other defined event types). The disclosure is material to investors assessing the company's development pipeline and regulatory strategy, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 5.03
Silo Pharma, Inc. implemented a 1-for-15 reverse stock split of its Common Stock, effective June 2, 2026, which proportionately reduced the Company's issued, outstanding, and authorized shares. This capital structure change affects share price, option and warrant exercise prices, and equity plan reserves, and may reflect efforts to address listing compliance requirements.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 8.01
TG Therapeutics disclosed positive Phase 1 clinical trial data for a subcutaneous formulation of ublituximab (BRIUMVI®) in relapsing multiple sclerosis. While clinical trial results can be material to investors assessing pipeline value and competitive positioning, this disclosure does not fit neatly into the more specific event categories (earnings_release, exec_departure, ma_activity, etc.). The positive PK/PD and safety data would reasonably affect an investor's assessment of the company's drug development prospects, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-03
The filing discloses entry into a material definitive agreement (Item 1.01) involving assignment of a debt instrument. While the transaction involves a related party and a previously impaired asset, it does not cleanly fit the standard taxonomy categories. The company assigned a $113,752 promissory note (original $100,000 principal plus $13,752 accrued interest) to SB Technology Holdings for $1,000 cash, reflecting the note's impaired status. This is material to investors as it involves a significant asset disposition and related-party transaction, but the event is best classified as "other_material" rather than forced into M&A or impairment categories, as it represents a debt assignment/disposition rather than a traditional acquisition or write-down disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 55%
filed 2026-06-03
Item 8.01
The Item 8.01 disclosure references multiple material transaction documents executed on May 31, 2026—including a Stock Purchase Agreement with Tacora Capital LP, a Loan Agreement with Cumberland Coal Corporation, a Subordination Agreement, and a Contingent Performance Note—but the actual substance of these transactions is not detailed in the 8-K text itself; it is incorporated by reference to the press release (Exhibit 99.1). Without access to the press release content, the precise nature of the transaction cannot be definitively classified. The structure suggests either a significant acquisition, financing arrangement, or restructuring involving Range Impact and Cumberland Coal entities, but the event type cannot be confidently assigned to ma_activity, dilutive_issuance, or covenant_breach without the exhibit details.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-03
Item 7.01
FingerMotion disclosed a strategic initiative to develop modular AI-focused edge computing infrastructure, representing a material expansion of the company's business strategy and long-term roadmap. While the disclosure is furnished under Item 7.01 (Regulation FD) rather than a more specific Item, the announcement of a new infrastructure business line targeting the AI inference market—described by the CEO as "a natural extension of our technology platform and a potential driver of long-term shareholder value"—would affect a reasonable investor's assessment of the company's growth prospects and capital allocation strategy. This does not fit neatly into M&A activity, earnings release, or other narrower categories, making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
The Board approved a four-for-one stock split effected as a stock dividend, with specified record and payment dates, affecting share count and equity valuation metrics.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-03
Item 8.01
OUTFRONT Media announced the pricing of $500 million in senior notes due 2034, a material debt issuance that affects the company's capital structure and financial obligations.
View raw filing on EDGAR →